Maravai LifeSciences
MRVI
$7.67
Share price
-0.65%
Change (1 day)
-46.62%
Change (1 year)
Categories
P/S ratio for Maravai LifeSciences (MRVI)
P/S ratio as of April 2024 (TTM): 6.67
According to Maravai LifeSciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.67337. At the end of 2023 the company had a P/S ratio of 5.70.
P/S ratio history for Maravai LifeSciences from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.70 | 37.73% |
| 2022 | 4.14 | -39.99% |
| 2021 | 6.89 | -27.78% |
| 2020 | 9.54 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 41.6 | 524.02% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 17.4 | 160.81% | 🇬🇧 UK |
 Novavax NVAX | 0.8375 | -87.45% | 🇺🇸 USA |
 Novocure
NVCR | 2.61 | -60.93% | Jersey |